<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(5)</volume><submitter>Abdelazeem NM</submitter><pubmed_abstract>Based on previous developments of our research programs in trying to find new compounds with multiple biological targets such as antioxidant, anti-diabetic, anti-Alzheimer's, and anti-arthritic agents. In the context, a novel series of sulfonamide derivatives based on the pyrazole or pyridine moieties &lt;b>3a, b, 7&lt;/b>-&lt;b>9, 11&lt;/b>-&lt;b>13, 15a, b,&lt;/b> and &lt;b>16&lt;/b> were synthesized from amine compounds with sulfonyl chloride derivatives. The structures of sulfonamide derivatives were elucidated &lt;i>via&lt;/i> spectroscopy (&lt;sup>1&lt;/sup>H and &lt;sup>13&lt;/sup>C NMR). The sulfonamide derivatives were biologically assessed &lt;i>in vitro&lt;/i> for their anti-diabetic (α-amylase and α-glucosidase inhibition) and anti-Alzheimer's (acetylcholinesterase inhibition) activities. The biological results revealed that compound &lt;b>15a&lt;/b> is a powerful enzyme inhibitor for α-amylase and α-glucosidase. Also, compound &lt;b>15b&lt;/b> demonstrated inhibitor activity against the acetylcholinesterase enzyme. The structure-activity relationship study of sulfonamide derivatives was accomplished. Furthermore, complementary &lt;i>in silico&lt;/i> molecular properties, drug-likeness, ADMET prediction, and surface properties of the two more powerful derivatives &lt;b>15a&lt;/b> and &lt;b>15b&lt;/b> were fulfilled and computed. These studies recommend &lt;b>15a&lt;/b> and &lt;b>15b&lt;/b> as candidates with modifications in their structures before the &lt;i>in vivo&lt;/i> assays.</pubmed_abstract><journal>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</journal><pagination>102025</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10973197</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis, &lt;i>in silico&lt;/i> ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents.</pubmed_title><pmcid>PMC10973197</pmcid><pubmed_authors>Naglah AM</pubmed_authors><pubmed_authors>Almehizia AA</pubmed_authors><pubmed_authors>Hassan AS</pubmed_authors><pubmed_authors>Aboulthana WM</pubmed_authors><pubmed_authors>Abdelazeem NM</pubmed_authors><pubmed_authors>Alkahtani HM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis, &lt;i>in silico&lt;/i> ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents.</name><description>Based on previous developments of our research programs in trying to find new compounds with multiple biological targets such as antioxidant, anti-diabetic, anti-Alzheimer's, and anti-arthritic agents. In the context, a novel series of sulfonamide derivatives based on the pyrazole or pyridine moieties &lt;b>3a, b, 7&lt;/b>-&lt;b>9, 11&lt;/b>-&lt;b>13, 15a, b,&lt;/b> and &lt;b>16&lt;/b> were synthesized from amine compounds with sulfonyl chloride derivatives. The structures of sulfonamide derivatives were elucidated &lt;i>via&lt;/i> spectroscopy (&lt;sup>1&lt;/sup>H and &lt;sup>13&lt;/sup>C NMR). The sulfonamide derivatives were biologically assessed &lt;i>in vitro&lt;/i> for their anti-diabetic (α-amylase and α-glucosidase inhibition) and anti-Alzheimer's (acetylcholinesterase inhibition) activities. The biological results revealed that compound &lt;b>15a&lt;/b> is a powerful enzyme inhibitor for α-amylase and α-glucosidase. Also, compound &lt;b>15b&lt;/b> demonstrated inhibitor activity against the acetylcholinesterase enzyme. The structure-activity relationship study of sulfonamide derivatives was accomplished. Furthermore, complementary &lt;i>in silico&lt;/i> molecular properties, drug-likeness, ADMET prediction, and surface properties of the two more powerful derivatives &lt;b>15a&lt;/b> and &lt;b>15b&lt;/b> were fulfilled and computed. These studies recommend &lt;b>15a&lt;/b> and &lt;b>15b&lt;/b> as candidates with modifications in their structures before the &lt;i>in vivo&lt;/i> assays.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2025-04-26T11:22:14.644Z</modification><creation>2025-04-06T13:40:25.972Z</creation></dates><accession>S-EPMC10973197</accession><cross_references><pubmed>38550332</pubmed><doi>10.1016/j.jsps.2024.102025</doi></cross_references></HashMap>